Drug Type Monoclonal antibody |
Synonyms + [1] |
Target |
Mechanism IL-23p19 inhibitors(Interleukin-23 subunit p19 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Qyuns Therapeutics Co., Ltd.Startup |
Active Organization Qyuns Therapeutics Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | CN | Qyuns Therapeutics Co., Ltd.Startup | 20 Sep 2023 |
Crohn Disease | Phase 1 | CN | Qyuns Therapeutics Co., Ltd.Startup | 02 Feb 2023 |